Alaunos Therapeutics, Inc.
TCRT
$2.63
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/4/2026
-
PR Newswire
3/27/2026
-
Ticker Report
3/2/2026
-
TipRanks Financial Blog
3/2/2026
-
The Fly
3/2/2026
-
Globe Newswire
2/18/2026
-
Ticker Report
2/1/2026
-
Ticker Report
12/28/2025
-
Ticker Report
12/23/2025
-
TipRanks Financial Blog
11/15/2025
-
Zolmax
10/29/2025
-
Ticker Report
10/22/2025
-
The Fly
10/6/2025
-
Ticker Report
8/21/2025
-
The Fly
8/9/2025
-
Ticker Report
7/30/2025
-
TipRanks Financial Blog
7/22/2025
-
TipRanks Financial Blog
7/10/2025
-
TipRanks Financial Blog
7/2/2025
-
TipRanks Financial Blog
6/23/2025
-
GuruFocus
6/23/2025
-
GuruFocus
6/23/2025
-
Seeking Alpha - Healthcare
6/23/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
346 355 4099
Address
501 E. Las Olas Blvd.
Fort Lauderdale, FL 33301
Fort Lauderdale, FL 33301
Country
Year Founded
Business Description
Sector
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic...
more